Kyllähän siitä massatestauksesta vaikka Etelä-Korean tyyliin suoraan autosta olisi paljonkin apua pandemian hidastamiseksi.
Testauskapasiteettia ei nyt vain saatavilla enempää, niin näillä mennään. Yhdysvalloissa on sama ongelma kapasiteetin kanssa ja esimerkiksi Johns Hopkinsin sairaalan ohjeissa se testaus on priorisoitu nyt noin:
Coronavirus COVID-19 (SARS-CoV-2) | Johns Hopkins ABX Guide
"Priorities for COVID-19 Testing†
|
| †Source: U.S. Centers for Disease Control. Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) Revised March 9, 2020. 1Fever may be subjective or confirmed 2For healthcare personnel, testing may be considered if there has been exposure to a person with suspected COVID-19 without laboratory confirmation. Because of their often extensive and close contact with vulnerable patients in healthcare settings, even mild signs and symptoms (e.g., sore throat) of COVID-19 should be evaluated among potentially exposed healthcare personnel. Additional information is available from CDC.[17] 3Close contact is defined as— a) being within approximately 6 feet (2 meters) of a COVID-19 case for a prolonged period of time; close contact can occur while caring for, living with, visiting, or sharing a healthcare waiting area or room with a COVID-19 case – or – b) having direct contact with infectious secretions of a COVID-19 case (e.g., being coughed on) If such contact occurs while not wearing recommended personal protective equipment or PPE (e.g., gowns, gloves, NIOSH-certified disposable N95 respirator, eye protection), criteria for PUI consideration are met. Additional information is available from CDC.[15] Data to inform the definition of close contact are limited. Considerations when assessing close contact include the duration of exposure (e.g., longer exposure time likely increases exposure risk) and the clinical symptoms of the person with COVID-19 (e.g., coughing likely increases exposure risk as does exposure to a severely ill patient). Special consideration should be given to healthcare personnel exposed in healthcare settings as described by CDC.[17] 4Documentation of laboratory-confirmation of COVID-19 may not be possible for travelers or persons caring for COVID-19 patients in other countries. 5Affected areas are defined as geographic regions where sustained community transmission has been identified. Relevant affected areas will be defined as a country with at least a CDC Level 2 Travel Health Notice. See all COVID-19 Travel Health Notices. |
